Păcurar Daniela, Dinulescu Alexandru, Prejmereanu Ana, Palcău Alexandru Cosmin, Dijmărescu Irina, Pavelescu Mirela-Luminița
Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Pediatrics, Emergency Hospital for Children "Grigore Alexandrescu", 011743 Bucharest, Romania.
J Clin Med. 2025 Sep 2;14(17):6202. doi: 10.3390/jcm14176202.
: The potential impact of maternal SARS-CoV-2 infection during pregnancy on the neurodevelopment of offspring has raised considerable concern. Emerging studies have evaluated various developmental domains in exposed infants, yet findings remain inconsistent. : To synthesize current evidence regarding neurodevelopmental outcomes in infants born to mothers with confirmed SARS-CoV-2 infection during pregnancy. Methods: We conducted a narrative review following PRISMA guidelines. A literature search was performed in PubMed, Cochrane, and ScienceDirect using keywords including "COVID-19", "pregnancy", "neurodevelopment", and "SARS-CoV-2". Nineteen studies were included. Data were extracted regarding study design, sample size, timing of exposure, age at assessment, developmental tools used, and key findings. Study quality was assessed using the Newcastle-Ottawa Scale. : Among 19 included studies, 12 reported at least some neurodevelopmental delays, particularly in motor and language domains. However, these delays were generally mild, domain-specific, and often not statistically significant. Seven studies, most of which were high-quality and low-risk, reported no significant differences between exposed and unexposed groups. Assessment tools and follow-up durations varied widely, limiting comparability. : Current evidence does not support a consistent association between in utero SARS-CoV-2 exposure and an unfavorable neurodevelopmental outcome up to 24 months. However, heterogeneity in methods and short-term follow-up warrant further high-quality longitudinal research.
孕期母亲感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对后代神经发育的潜在影响引起了广泛关注。新兴研究评估了暴露婴儿的各个发育领域,但研究结果仍不一致。:综合当前关于孕期确诊感染SARS-CoV-2的母亲所生婴儿神经发育结局的证据。方法:我们按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行了叙述性综述。在PubMed、Cochrane和ScienceDirect数据库中进行文献检索,使用的关键词包括“2019冠状病毒病”“妊娠”“神经发育”和“SARS-CoV-2”。纳入了19项研究。提取了有关研究设计、样本量、暴露时间、评估年龄、使用的发育工具以及主要研究结果的数据。使用纽卡斯尔-渥太华量表评估研究质量。:在纳入的19项研究中,12项报告了至少一些神经发育延迟,特别是在运动和语言领域。然而,这些延迟通常较轻,具有领域特异性,且往往无统计学意义。7项研究(其中大多数为高质量和低风险研究)报告暴露组和未暴露组之间无显著差异。评估工具和随访时间差异很大,限制了可比性。:目前的证据不支持子宫内SARS-CoV-2暴露与24个月内不良神经发育结局之间存在一致关联。然而,方法的异质性和短期随访需要进一步开展高质量的纵向研究。